GSK Drug Cabenuva with two month dosing gets the FDA Nod
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was...
Last year, GlaxoSmithKline’s ViiV Healthcare’s feat of getting a long-awaited approval of HIV treatment by the name of Cabenuva was...
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain...
German independent research institute BioMed X announces the extension of its collaboration with Merck KGaA, Darmstadt, Germany, in the research...
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, announced that its VP3 multidose...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Israel's Ministry of...
Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal...
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced that it has entered...
Sharp, a global leader in contract packaging and clinical supply services, has completed the construction of new purpose-built production suites...
Evotec announced that the Company has entered a target and drug discovery partnership with Boehringer Ingelheim, focusing on induced pluripotent...
Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
